Refine by
Health Threat Articles & Analysis: Older
61 news found
As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist researchers, pharmaceutical companies, and healthcare providers in developing new antimicrobial agents that could shape the future of infectious disease treatment. ...
Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) are major global health threats. Their interaction worsens disease severity, as HIV reduces CD4+ T cells, making individuals more vulnerable to TB. ...
This project has been funded in whole or in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. 75A50122C00025. ...
“We look forward to combining our product development expertise with the capabilities of AFRIMS in chikungunya epidemiology and field studies, and of our academic partners in infectious disease modeling and efficacy trial design, to find ways to address chikungunya disease, a public health threat for which no vaccine or treatment exists.” AFRIMS is a ...
Among the four initial A.C.T.S. awardees are two companies: Framingham-based Kephera Diagnostics and Wellesley-based Virex Health; and two research hospitals: Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital. ...
The clinical studies received the requisite ethics approvals from Health Canada and Western IRB prior to commencement in December 2018. ...
The availability of this innovative test provides a valuable tool in the growing global threat posed by antimicrobial resistance (AMR). According to the World Health Organization, AMR is in fact, one of the top 10 global public health threats for humanity and it is estimated to kill 700,000 people a year worldwide, 33,000 across ...
ByMeMed
BFS is cost-efficient for short and long runs, and highly suitable to scale quickly in order to meet unexpected spikes in demand such as for a rapid response to population-scale health emergencies. Advancements developed by ApiJect for temperature management now enable BFS manufacturing of a vast array of sterile injectable drugs, including ultra-cold mRNA vaccines. ApiJect ...
THOUSAND OAKS, Calif., May 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Otezla® (apremilast) have partnered with pop icon and entrepreneur Lance Bass, for the Double Take campaign to empower people to take action when it comes to psoriatic arthritis. As a singer, dancer and entertainer, Bass understands the importance of staying in tune with your body. Through the campaign, he has created ...
The self-replicating and plug-and-play features of the platform is designed to enable efficient, versatile, and rapid responses to health threats by allowing for lower doses and the ability to code for any protein of interest. ...
In October 2021, the company received a $2.8 million award from the U.S. National Institutes of Health (NIH) to help commercialization efforts. The U.S. Centers for Disease Control and Prevention (CDC) has cited bacterial resistance to antibiotics among the world's deadliest and costliest health threats. ...
We are very pleased about this external validation from the FDA and we are looking forward to advancing zapnometinib towards full development in this indication, which is considered an emerging global health threat due to man-made environmental and climatic changes. I am very proud of the excellent scientific research that has yielded convincing results enabling ...
The Biomedical Advanced Research and Development Authority (BARDA) is a component of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services and is focused on the development of medical countermeasures to protect Americans and respond to 21st-century health security threats. ...
Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19. ...
Ferring is committed to exploring the crucial link between the microbiome and human health, beginning with the threat of recurrent C. difficile infection. ...
Ferring is committed to exploring the crucial link between the microbiome and human health, beginning with the threat of recurrent C. difficile infection. ...
Diabetes Related Enzymes: Diabetes has developed into one of the most serious health threats to the public in the world. According to reports, many factors are related to the deterioration of diabetes, such as increasing urbanization, changes in diet, reduction in exercise, unhealthy lifestyles, and aging of the population. ...
“C. difficile infection is a global public health threat that requires immediate action to halt the unrelenting cycle of recurrence. ...
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against ...
“The risk of falling for older adults in Colorado is a serious public health threat post-pandemic as Americans venture out again, in some cases for the first time after months of inactivity,” said Jayla Sanchez-Warren, director for DRCOG’s Area Agency on Aging. ...